Aphasia, Primary Progressive: Clinical Trials

1 trial for Aphasia, Primary Progressive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Aphasia, Primary Progressive: new trials by email Literature Review of Aphasia, Primary Progressive trials Research Report on Aphasia, Primary Progressive

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
AADvac1 40 µg, AADvac1 160 µg - Primary Progressive Nonfluent Aphasia
Phase 1UnknownAxon Neuroscience SE332017-07-312019-11-14

Narrower conditions

Pick Disease of the Brain (1)  ·  Primary Progressive Nonfluent Aphasia (1)  ·  Tauopathies (1)

Broader conditions

Aphasia (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Dementia (1)  ·  Frontotemporal Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Language Disorders (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

AADvac1 (1)

Sponsors

Axon Neuroscience SE (1)

Countries

Germany (1)

Top investigators

Markus Otto, Prof (1)

NIH funding

2017 (1)